Target intelligence / Profile preview

H2A.Z.1 divergent transcript (H2AZ1-DT)

Target
H2AZ1-DT
Molecular classification
Other (divergent transcript, likely non-coding RNA)
01

Overview

The "H2AZ1 divergent transcript" (H2AZ1-DT) refers to an RNA molecule produced by divergent (typically non-coding, often antisense or bidirectional) transcription at the promoter region of the *H2A.Z.1* (H2AFZ) gene. Such divergent transcripts are a widespread feature of eukaryotic chromatin structure and are especially prominent at nucleosome-depleted regions flanked by nucleosomes incorporating the histone variant H2A.Z[3]. While H2A.Z.1 is a well-studied histone protein involved in gene regulation, DNA repair, and chromatin dynamics[1][5], "H2AZ1 divergent transcript" itself is not a protein-coding gene, does not encode a therapeutic target, and has not been shown to possess direct biological or disease relevance. Instead, it arises as a byproduct or potential regulator of the complex transcriptional landscape near gene promoters and terminators[3].

Other names
antisense H2A.Z.1 transcriptdivergent transcript at H2AFZ locus
02

Biological functions

Other (possible roles in local chromatin structure or gene regulation, but no direct evidence as a functional protein or classical target)
03

Disease associations

Other (no known direct involvement in disease; the protein product H2A.Z.1 is involved in chromatin regulation and may be implicated in cancer, but the "H2AZ1 divergent transcript" itself is not characterized as disease-associated)

Beyond the preview

Go deeper on H2A.Z.1 divergent transcript (H2AZ1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on H2A.Z.1 divergent transcript (H2AZ1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call